ACSL4 and neoplasm: It has recently been shown that Acyl-CoA Synthetase Long Chain 4 (ACSL4) enhances the expression of lipogenic enzymes through the c-Myc/SREBP1 oncogene signaling; however more studies are needed to determine the association between ACSL4, metabolism and tumor lipid abnormalities (Chen et al., 2021).